TOMMASI RUBEN (Chief Science Officer) received a stock award from ENTASIS THERAPEUTICS HOLDINGS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/19/2022ACC: 0001104659-22-005430
Officer· Chief Science Officer
Since Sep 2018
+125K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
125K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+125K
Price / share
—
Trade value
—
% of position
193.5%
1/18/2022
64.60K→189.60K
Total
Net shares
+125K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/18/2022 | A · Award | +125K | — | — | 193.5% | 64.60K | 189.60K |
| Total | +125K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported